These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 29296254)

  • 1. Extracellular vesicles yield predictive pre-eclampsia biomarkers.
    Tan KH; Tan SS; Ng MJ; Tey WS; Sim WK; Allen JC; Lim SK
    J Extracell Vesicles; 2017; 6(1):1408390. PubMed ID: 29296254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma biomarker discovery in preeclampsia using a novel differential isolation technology for circulating extracellular vesicles.
    Tan KH; Tan SS; Sze SK; Lee WK; Ng MJ; Lim SK
    Am J Obstet Gynecol; 2014 Oct; 211(4):380.e1-13. PubMed ID: 24657793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membrane lipids define small extracellular vesicle subtypes secreted by mesenchymal stromal cells.
    Lai RC; Lim SK
    J Lipid Res; 2019 Feb; 60(2):318-322. PubMed ID: 30154233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of pre-eclampsia and its subtypes in high-risk cohort: hyperglycosylated human chorionic gonadotropin in multivariate models.
    Murtoniemi K; Villa PM; Matomäki J; Keikkala E; Vuorela P; Hämäläinen E; Kajantie E; Pesonen AK; Räikkönen K; Taipale P; Stenman UH; Laivuori H
    BMC Pregnancy Childbirth; 2018 Jul; 18(1):279. PubMed ID: 29970026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia.
    Chaiworapongsa T; Romero R; Whitten AE; Korzeniewski SJ; Chaemsaithong P; Hernandez-Andrade E; Yeo L; Hassan SS
    J Matern Fetal Neonatal Med; 2016; 29(8):1214-28. PubMed ID: 26303962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MSC secretes at least 3 EV types each with a unique permutation of membrane lipid, protein and RNA.
    Lai RC; Tan SS; Yeo RW; Choo AB; Reiner AT; Su Y; Shen Y; Fu Z; Alexander L; Sze SK; Lim SK
    J Extracell Vesicles; 2016; 5():29828. PubMed ID: 26928672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of copeptin, placental growth factor and total annexin V microparticles for prediction of preeclampsia at 10-14 weeks of gestation.
    Jadli A; Ghosh K; Satoskar P; Damania K; Bansal V; Shetty S
    Placenta; 2017 Oct; 58():67-73. PubMed ID: 28962698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal serum placental growth factor at 11 + 0 to 13 + 6 weeks of gestation in the prediction of pre-eclampsia.
    Akolekar R; Zaragoza E; Poon LC; Pepes S; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Nov; 32(6):732-9. PubMed ID: 18956425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. sFlt-1/PlGF for prediction of early-onset pre-eclampsia: STEPS (Study of Early Pre-eclampsia in Spain).
    Perales A; Delgado JL; de la Calle M; García-Hernández JA; Escudero AI; Campillos JM; Sarabia MD; Laíz B; Duque M; Navarro M; Calmarza P; Hund M; Álvarez FV;
    Ultrasound Obstet Gynecol; 2017 Sep; 50(3):373-382. PubMed ID: 27883242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addition of N-terminal pro-B natriuretic peptide to soluble fms-like tyrosine kinase-1/placental growth factor ratio > 38 improves prediction of pre-eclampsia requiring delivery within 1 week: a longitudinal cohort study.
    Sabriá E; Lequerica-Fernández P; Lafuente-Ganuza P; Eguia-Ángeles E; Escudero AI; Martínez-Morillo E; Barceló C; Álvarez FV
    Ultrasound Obstet Gynecol; 2018 Jun; 51(6):758-767. PubMed ID: 29498431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Competing-risks model in screening for pre-eclampsia in twin pregnancy according to maternal factors and biomarkers at 11-13 weeks' gestation.
    Francisco C; Wright D; Benkő Z; Syngelaki A; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Nov; 50(5):589-595. PubMed ID: 28556556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Placental growth factor (alone or in combination with soluble fms-like tyrosine kinase 1) as an aid to the assessment of women with suspected pre-eclampsia: systematic review and economic analysis.
    Frampton GK; Jones J; Rose M; Payne L
    Health Technol Assess; 2016 Nov; 20(87):1-160. PubMed ID: 27918253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of diagnostic accuracy of early screening for pre-eclampsia by NICE guidelines and a method combining maternal factors and biomarkers: results of SPREE.
    Tan MY; Wright D; Syngelaki A; Akolekar R; Cicero S; Janga D; Singh M; Greco E; Wright A; Maclagan K; Poon LC; Nicolaides KH
    Ultrasound Obstet Gynecol; 2018 Jun; 51(6):743-750. PubMed ID: 29536574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of urinary soluble endoglin in the diagnosis of pre-eclampsia: comparison with soluble fms-like tyrosine kinase 1 to placental growth factor ratio.
    Buhimschi CS; Baumbusch MA; Dulay AT; Lee S; Wehrum M; Zhao G; Bahtiyar MO; Pettker CM; Ali UA; Funai EF; Buhimschi IA
    BJOG; 2010 Feb; 117(3):321-30. PubMed ID: 19943826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of pregnancies after combined screening for pre-eclampsia at 19-24 weeks' gestation.
    Litwinska M; Syngelaki A; Wright A; Wright D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2018 Sep; 52(3):365-372. PubMed ID: 29943498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OS043. Identification and validation of novel markers for the predictionof pre-eclampsia.
    Myers J; Tuytten R; Thomas G; McCowan L; Dekker G; Baker P; Poston L; Kenny L; Simpson N; North R
    Pregnancy Hypertens; 2012 Jul; 2(3):200. PubMed ID: 26105257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of angiogenic factors, clinical risk factors and uterine artery Doppler for pre-eclampsia and fetal growth restriction in second and third trimester pregnancies in an Ecuadorian population.
    Kienast C; Moya W; Rodriguez O; Jijón A; Geipel A
    J Matern Fetal Neonatal Med; 2016; 29(4):537-43. PubMed ID: 25708492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal changes in maternal serum placental growth factor and soluble fms-like tyrosine kinase-1 in women at increased risk of pre-eclampsia.
    Khalil A; Maiz N; Garcia-Mandujano R; Penco JM; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Mar; 47(3):324-31. PubMed ID: 26387758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiogenic factors combined with clinical risk factors to predict preterm pre-eclampsia in nulliparous women: a predictive test accuracy study.
    Myers JE; Kenny LC; McCowan LM; Chan EH; Dekker GA; Poston L; Simpson NA; North RA;
    BJOG; 2013 Sep; 120(10):1215-23. PubMed ID: 23906160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined screening for early and late pre-eclampsia and intrauterine growth restriction by maternal history, uterine artery Doppler, mean arterial pressure and biochemical markers.
    Litwińska E; Litwińska M; Oszukowski P; Szaflik K; Kaczmarek P
    Adv Clin Exp Med; 2017; 26(3):439-448. PubMed ID: 28791818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.